Literature DB >> 15693789

Bronchoalveolar lavage in immunocompromised patients with haematological malignancy--value of new microbiological methods.

U Hohenthal1, M Itälä, J Salonen, J Sipilä, K Rantakokko-Jalava, O Meurman, J Nikoskelainen, R Vainionpää, P Kotilainen.   

Abstract

PURPOSE: To assess the usefulness of new culture-independent microbiological methods to analyse bronchoalveolar lavage (BAL) fluid from haematological patients with clinical pneumonia. PATIENTS AND METHODS: Results of 135 BALs from 122 disease episodes in 99 patients treated between 1996 and 2002 were retrospectively analysed. Forty-three patients had undergone haematopoietic stem cell transplantation and 56 patients had been treated with conventional chemotherapy for haematological malignancy. In addition to conventional microbiological methods, polymerase chain reaction (PCR) tests for Pneumocystis carinii, cytomegalovirus (CMV), Legionella sp., mycobacterium, Mycoplasma pneumoniae, and Chlamydia pneumoniae and the Aspergillus antigen test were performed.
RESULTS: Three (2.2%) quantitative and four (3.0%) special bacterial cultures gave an aetiological diagnosis. A respiratory virus was isolated in 10 episodes (8.2%). The diagnostic yield increased to 35.6% (48 of 135) by other methods. The P. carinii PCR test was positive in 21 of 24 patients with P. carinii pneumonia, being the only microbiological indication of P. carinii in four cases. The CMV PCR test was positive in 18 patients, but in 14 patients the clinical significance of the finding remained unproven. The Aspergillus antigen test was positive in seven of nine patients with aspergillosis, being the only microbiological indication of Aspergillus in three cases. The result of BAL indicated commencement of specific antimicrobial treatment in 27 episodes (22.1%).
CONCLUSION: The contribution of new culture-independent methods to the total diagnostic yield was of note. Among these methods, the P. carinii PCR and Aspergillus antigen tests proved the most valuable, while the CMV PCR test was not clinically useful.

Entities:  

Mesh:

Year:  2005        PMID: 15693789     DOI: 10.1111/j.1600-0609.2004.00373.x

Source DB:  PubMed          Journal:  Eur J Haematol        ISSN: 0902-4441            Impact factor:   2.997


  18 in total

Review 1.  Diagnostic strategy in cancer patients with acute respiratory failure.

Authors:  Elie Azoulay; Benoît Schlemmer
Journal:  Intensive Care Med       Date:  2006-04-29       Impact factor: 17.440

Review 2.  Pneumonia in the neutropenic cancer patient.

Authors:  Scott E Evans; David E Ost
Journal:  Curr Opin Pulm Med       Date:  2015-05       Impact factor: 3.155

3.  Host lung gene expression patterns predict infectious etiology in a mouse model of pneumonia.

Authors:  Scott E Evans; Michael J Tuvim; Jiexin Zhang; Derek T Larson; Cesar D García; Sylvia Martinez-Pro; Kevin R Coombes; Burton F Dickey
Journal:  Respir Res       Date:  2010-07-23

4.  Asymptomatic carriage of Pneumocystis jirovecii and cytomegalovirus in lungs of immunocompetent patients.

Authors:  Michal Shteinberg; Pninit Shaked-Mishan; Amalia Kinarti; Amir Abramovitch; Anat Amital; Assaf Jacobi; Aharon E Kolup Feldmann; Maayan Shiner; Vladimir Gershtein; Gabriel Weber; Yochai Adir
Journal:  Lung       Date:  2014-09-09       Impact factor: 2.584

5.  Lung epithelial cells are essential effectors of inducible resistance to pneumonia.

Authors:  J O Cleaver; D You; D R Michaud; F A Guzmán Pruneda; M M Leiva Juarez; J Zhang; P M Weill; R Adachi; L Gong; S J Moghaddam; M E Poynter; M J Tuvim; S E Evans
Journal:  Mucosal Immunol       Date:  2013-05-01       Impact factor: 7.313

Review 6.  Evaluation of PCR on bronchoalveolar lavage fluid for diagnosis of invasive aspergillosis: a bivariate metaanalysis and systematic review.

Authors:  Wenkui Sun; Ke Wang; Wei Gao; Xin Su; Qian Qian; Xin Lu; Yong Song; Yaling Guo; Yi Shi
Journal:  PLoS One       Date:  2011-12-02       Impact factor: 3.240

7.  Galactomannan detection in broncho-alveolar lavage fluid for invasive aspergillosis in immunocompromised patients.

Authors:  Koen de Heer; Marije G Gerritsen; Caroline E Visser; Mariska Mg Leeflang
Journal:  Cochrane Database Syst Rev       Date:  2019-05-20

8.  Measurement of complement receptor 1 on neutrophils in bacterial and viral pneumonia.

Authors:  Ulla Hohenthal; Jari Nuutila; Esa-Matti Lilius; Iina Laitinen; Jukka Nikoskelainen; Pirkko Kotilainen
Journal:  BMC Infect Dis       Date:  2006-01-24       Impact factor: 3.090

9.  Morphine compromises bronchial epithelial TLR2/IL17R signaling crosstalk, necessary for lung IL17 homeostasis.

Authors:  Santanu Banerjee; Jana Ninkovic; Jingjing Meng; Umakant Sharma; Jing Ma; Richard Charboneau; Sabita Roy
Journal:  Sci Rep       Date:  2015-06-15       Impact factor: 4.379

10.  Association of bronchoalveolar lavage yield with chest computed tomography findings and symptoms in immunocompromised patients.

Authors:  Kyle R Brownback; Steven Q Simpson
Journal:  Ann Thorac Med       Date:  2013-07       Impact factor: 2.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.